Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported its highest-ever quarterly revenue and profits, demonstrating a strong start to FY27 with a record revenue growth of 51% and EBITDA growth of 39% year-on-year.
- The growth was significantly driven by the successful integration and rapid ramp-up of newer hospitals, which collectively contributed 27% to the revenue mix, validating the company's acquisition and turnaround strategy.
- A key highlight was the Faridabad Sector 20 hospital achieving EBITDA break-even within a record nine months, significantly ahead of schedule, while operating with a favorable payor mix of over 90% cash and private insurance patients.
- The company demonstrated a meaningful improvement in profitability, with adjusted EBITDA margins (excluding new hospitals) reaching 28.1%, driven by operating leverage and a stronger specialty mix, particularly in oncology.
- In a move reflecting confidence in future performance and a commitment to shareholder value, the Board approved a maiden interim dividend and launched a new ESOP scheme to attract and retain talent.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.